Unmet needs with antipsychotic treatment in schizophrenia and bipolar I disorder: patient perspectives from qualitative focus groups

被引:0
|
作者
Michael J. Doane
Kimberly Raymond
Cory Saucier
Leona Bessonova
Amy K. O’Sullivan
Michelle K. White
April Mitchell Foster
Kaitlin LaGasse
Julia Carpenter-Conlin
Martha Sajatovic
Dawn I. Velligan
机构
[1] Alkermes,
[2] Inc.,undefined
[3] QualityMetric,undefined
[4] Inc. LLC,undefined
[5] University Hospitals Cleveland Medical Center,undefined
[6] The University of Texas Health Science Center at San Antonio,undefined
来源
关键词
Antipsychotics; Drug side effects; Focus groups; Patient involvement; Patient preference;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Users' Perspectives on mHealth Self-Management of Bipolar Disorder: Qualitative Focus Group Study
    Switsers, Lise
    Dauwe, Arthur
    Vanhoudt, Anneleen
    Van Dyck, Hilde
    Lombaerts, Koen
    Oldenburg, J. F. E.
    JMIR MHEALTH AND UHEALTH, 2018, 6 (05):
  • [32] Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder
    Bishara, Delia
    Taylor, David
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2009, 5 : 483 - 490
  • [33] Asenapine Treatment in Pediatric Patients with Bipolar I Disorder or Schizophrenia: A Review
    Ekaterina Stepanova
    Bradley Grant
    Robert L. Findling
    Pediatric Drugs, 2018, 20 : 121 - 134
  • [34] Asenapine Treatment in Pediatric Patients with Bipolar I Disorder or Schizophrenia: A Review
    Stepanova, Ekaterina
    Grant, Bradley
    Findling, Robert L.
    PEDIATRIC DRUGS, 2018, 20 (02) : 121 - 134
  • [35] Visually impaired caregivers: Perspectives from patient focus groups
    Martinez, Bethany S.
    Williams, Michael
    Fuhr, Patti
    OPTOMETRY-JOURNAL OF THE AMERICAN OPTOMETRIC ASSOCIATION, 2009, 80 (01) : 11 - 22
  • [36] The impact of diabetic retinopathy: perspectives from patient focus groups
    Coyne, KS
    Margolis, MK
    Kennedy-Martin, T
    Baker, TM
    Klein, R
    Paul, MD
    Revicki, DA
    FAMILY PRACTICE, 2004, 21 (04) : 447 - 453
  • [37] BUDGET IMPACT OF LYBALVI® FOR THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR I DISORDER FROM A US PAYER PERSPECTIVE
    Doane, M.
    O'Sullivan, A. K.
    Ottino, K.
    Eichten, C.
    VALUE IN HEALTH, 2022, 25 (07) : S365 - S365
  • [38] Utilizing Asynchronous Email Interviewing for Qualitative Research Among Multiple Participant Groups: Perspectives on Met and Unmet Needs From Chaplain Staffing
    Harris, Stephanie L.
    Shaw, Martin
    Green, Jeanette F.
    INTERNATIONAL JOURNAL OF QUALITATIVE METHODS, 2024, 23
  • [39] PREFERENCES FOR ATTRIBUTES OF ORAL ANTIPSYCHOTIC TREATMENTS: SURVEY RESULTS OF PATIENTS LIVING WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER
    Doane, M.
    Boeri, M.
    Panchmatia, H.
    Citrome, L.
    Sajatovic, M.
    VALUE IN HEALTH, 2023, 26 (06) : S320 - S320
  • [40] Preferences for attributes of oral antipsychotic treatments: results from a discrete-choice experiment in respondents with schizophrenia or bipolar I disorder
    Doane, Michael J.
    Boeri, Marco
    Vass, Caroline
    Bussberg, Cooper
    Panchmatia, Hemangi R.
    Citrome, Leslie
    Sajatovic, Martha
    BMC PSYCHIATRY, 2024, 24 (01)